From Carer to Trailblazer: One Man’s Fight to Impact Clinical Research episode artwork

EPISODE · Dec 6, 2022 · 20 MIN

From Carer to Trailblazer: One Man’s Fight to Impact Clinical Research

from PharmaTalkRadio · host Conference Forum

When Claas Röhl’s 12-year old daughter was an infant, she was diagnosed with Neurofibromatosis Type 1 (NF), a rare genetic disorder that causes tumors to form along nerves. With no prior background in research, Claas founded NF Kinder and became an advocate for his daughter and patients impacted by this rare disorder. Claas will discuss his involvement in research, how he helped set up the first pediatric department for NF at a major medical University in Austria, and his efforts to create a national registry of NF patients. He will share lessons learned and offer insights on how best to engage carers to impact clinical research. Claas Röhl, Chairman, NF Kinder, EUPATI Austria, NF PatientsUnited  with: Renata Lazarova, MD, VP Development, Pediatric Programs, Noema Pharma Learn more about the Patients as Partners EU conference at www.patientsaspartners.org

When Claas Röhl’s 12-year old daughter was an infant, she was diagnosed with Neurofibromatosis Type 1 (NF), a rare genetic disorder that causes tumors to form along nerves. With no prior background in research, Claas founded NF Kinder and became an advocate for his daughter and patients impacted by this rare disorder. Claas will discuss his involvement in research, how he helped set up the first pediatric department for NF at a major medical University in Austria, and his efforts to create a national registry of NF patients. He will share lessons learned and offer insights on how best to engage carers to impact clinical research. Claas Röhl, Chairman, NF Kinder, EUPATI Austria, NF PatientsUnited  with: Renata Lazarova, MD, VP Development, Pediatric Programs, Noema Pharma Learn more about the Patients as Partners EU conference at www.patientsaspartners.org

NOW PLAYING

From Carer to Trailblazer: One Man’s Fight to Impact Clinical Research

0:00 20:05

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of PharmaTalkRadio?

This episode is 20 minutes long.

When was this PharmaTalkRadio episode published?

This episode was published on December 6, 2022.

What is this episode about?

When Claas Röhl’s 12-year old daughter was an infant, she was diagnosed with Neurofibromatosis Type 1 (NF), a rare genetic disorder that causes tumors to form along nerves. With no prior background in research, Claas founded NF Kinder and became an...

Can I download this PharmaTalkRadio episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!